Category - Pharmaceuticals Market Research Report

Zearalenone Antibody Market Size, Share & Trends Analysis Report, By Type (Polyclonal, Monoclonal); By Application (Enzyme Linked Immunosorbent Assay, Immunocytochemistry, Immunofluorescence & Others), By Region, Forecasts, 2024-2031

The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031 at an 18.7% CAGR during the forecast period for 2024-2031. Zearalenone antibodies can detect and bind to the mycotoxin zearalenone...

View Sample PDF

Gene Switch / Molecular Switch Market, Share & Trends Analysis Report, Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy), Type of Payment Model Employed, By Region, and Segment Forecasts, 2024-2031

The Gene Switch / Molecular Switch Market Size is valued at USD 0.69 Bn in 2023 and is predicted to reach USD 1.44 Bn by the year 2031 at an 9.9% CAGR during the forecast period for 2024-2031. Gene switches are locations on genes that are capable ...

View Sample PDF

Recombinant Human Endostatin Market Size, Share & Trends Analysis Report By Type (purity 95% and others) And By Application (medical care, scientific research and others), By Region, And By Segment Forecasts, 2024-2031

The Recombinant Human Endostatin Market Size is valued at USD 133.3 Mn in 2023 and is predicted to reach USD 249.4 Mn by the year 2031 at a 8.3% CAGR during the forecast period for 2024-2031. Recombinant human endostatin is a naturally occurring p...

View Sample PDF

Periodontal Therapeutics Market Size, Share & Trends Analysis Report, By Disease (Chronic Periodontal Disease, Aggressive Periodontal Disease, Gingivitis), By Drug Type (Doxycycline, Minocycline, Chlorhexidine, Metronidazole)), By Distribution Channel, By Region, Forecasts, 2024-2031

The Periodontal Therapeutics Market Size was valued at USD 843.6 Mn in 2023 and is predicted to reach USD 1,497.4 Mn by 2031 at a 7.6% CAGR during the forecast period for 2024-2031. Periodontal disease encompasses a wide range of inflammatory cond...

View Sample PDF

Radionuclide_Drug_Conjugates_(RDC)_Market.JPG

Radionuclide Drug Conjugates (RDC) Market Size, Share & Trends Analysis Distribution by Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma) and Segment Forecasts, 2024-2031

Radionuclide Drug Conjugates (RDC) Market Size is predicted to witness a 13.9% of CAGR during the forecast period for 2024-2031. Radionuclide Drug Conjugates (RDCs) represent a promising innovation in cancer treatment, utilizing a targeted approac...

View Sample PDF

Disseminated_Intravascular_Coagulation_(DIC)_Market.JPG

Disseminated Intravascular Coagulation (DIC) Market Size, Share & Trends Analysis Report By Symptoms (Bleeding, Blood Clots, Bruising, Drop in Blood Pressure, Shortness of Breath, Confusion, Fever), Treatment (Medicines, Transfusions, Surgery), Diagnosis (Complete Blood Count with Blood Smear Exam, Partial Thromboplastin Time (PTT), Prothrombin Time (PT), Fibrinogen Blood Test, D-dimer), Route of Administration, End-Users, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031.

Disseminated Intravascular Coagulation (DIC) Market Size is valued at USD 437.3 Mn in 2023 and is predicted to reach USD 563.8 Mn by the year 2031 at a 3.3% CAGR during the forecast period for 2024-2031. The Disseminated Intravascular Coagulation ...

View Sample PDF

Long_Acting_Drug_Delivery_Technologies_Services_Market.JPG

Long Acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered, Material Used And End-User, Region And Segment Forecasts, 2023-2031

Global Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031 at a 10.6% CAGR during the forecast period for 2024-2031. The global long-acting drug delive...

View Sample PDF

Cytotoxic Drugs and HPAPI Manufacturing Market Size, Share & Trends Analysis Distribution by Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large, Very Large), Scale of Operation (Preclinical, clinical, commercial), Type of Molecule (Small molecules, biologics), Type of Highly Potent Finished Dosage Form (Injectables, oral solids, creams and others), and Segment Forecasts, 2023-2031

Cytotoxic Drugs and HPAPI Manufacturing Market Size is valued at USD 10.7 Bn in 2023 and is predicted to reach USD 27.1 Bn by the year 2031 at an 12.5% CAGR during the forecast period for 2024-2031. Cytotoxic drugs and high-potency active pharmace...

View Sample PDF

Insulin-like Growth Factors Market Share & Trends Analysis Report, By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), By Region, and Segment Forecasts, 2023-2031

Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 at an 5.13% CAGR during the forecast period for 2024-2031. Insulin-like growth factors (IGFs) are proteins that resem...

View Sample PDF

Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market Size, Share & Trends Analysis by Disease (Neurological Disorders and Dystrophies, Cardiac disorders, Retinal Eye Disease, Metabolic Disorders, Liver disease, Others), Products and Services (Disease Model, Reprogramming service, Differentiation service, Screening service, Characterization service, Others), and Segment Forecasts, 2023-2031

Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market Size is predicted to grow at an 11.2% CAGR during the forecast period for 2024-2031. Human-induced pluripotent stem cells (hiPSCs) are a pivotal tool in bio...

View Sample PDF

Pharmaceuticals

Categories